STOCK TITAN

Neogen Corp SEC Filings

NEOG Nasdaq

Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Food safety diagnostics might feel far from Wall Street, yet Neogen’s supply-chain complexity shows up in hundreds of pages of disclosures. Tracking which genomic test kit drives revenue, or when management sells shares, is difficult. That’s why investors hunting for “Neogen insider trading Form 4 transactions” or the latest “Neogen quarterly earnings report 10-Q filing” often lose hours scrolling through EDGAR.

Stock Titan fixes this. Our AI reads every 10-K, 10-Q, 8-K and proxy the moment it is released, pushes “Neogen Form 4 insider transactions real-time” to your dashboard, and offers “Neogen SEC filings explained simply” with crisp language and data visualizations. Within seconds you’ll see a “Neogen earnings report filing analysis,” flagging segment sales for food safety, animal safety and genomics, plus cash flow shifts tied to acquisitions. Interactive links jump you straight to risk factors, while sidebars answer “understanding Neogen SEC documents with AI” without legalese.

Want specifics? The “Neogen annual report 10-K simplified” highlights R&D spend on LAMP molecular assays and global compliance costs. The “Neogen proxy statement executive compensation” module benchmarks pay packages against peer diagnostics firms. Alerts on “Neogen executive stock transactions Form 4” reveal buying patterns before material announcements, and our dashboard keeps the “Neogen 8-K material events explained” in plain sight when recalls or mergers hit. Whether you compare quarter-over-quarter allergen test kit sales, monitor insider sentiment, or review governance votes, Stock Titan delivers the intelligence you need, updated in real time and ready for decision making.

Rhea-AI Summary

NEOGEN CORP (NEOG) director Rafael A. Rodriguez received 2,071 restricted stock units that vested and were settled into 2,071 shares of common stock on 10/07/2025. The reported per-share value on the transaction is $5.63, and Mr. Rodriguez's total beneficial ownership after the settlement is 17,019 shares held directly. The filing is a Form 4 disclosure of an insider vesting event rather than a market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.49%
Tags
insider
-
Rhea-AI Summary

Ashima Gupta, a director of Neogen Corporation (NEOG), reported the vesting and settlement of 2,071 restricted stock units (RSUs) into 2,071 shares of common stock on 10/07/2025. The reported per‑share value recorded on the form is $5.63, and the reporting form shows 23,988 shares beneficially owned by the reporting person following this transaction.

The filing is a routine Section 16 disclosure showing compensation‑related equity vesting rather than an open‑market buy or sell. The form was signed by an attorney‑in‑fact on 10/09/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.49%
Tags
insider
-
Rhea-AI Summary

Neogen Corp director Ronald D. Green had 2,071 restricted stock units (RSUs) vest on 10/07/2025 and those RSUs were settled into an equal number of shares of common stock at an effective price of $5.63 per share. After the settlement, Mr. Green directly owned 14,852 shares. The Form 4 was signed by an attorney-in-fact on 10/09/2025. The filing records a routine equity compensation settlement rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.49%
Tags
insider
Rhea-AI Summary

Jeffrey D. Capello, a director of Neogen Corporation (NEOG), had 2,071 restricted stock units vest and settle on 10/07/2025.

The settlement converted the RSUs into 2,071 shares of common stock at an indicated unit price of $5.63, bringing his total beneficial ownership to 28,700 shares following the transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.49%
Tags
insider
-
Rhea-AI Summary

Insider report: A director of Neogen Corporation (NEOG) had 2,071 restricted stock units vest and be settled for 2,071 shares of common stock on 10/07/2025. The transaction is recorded as a vesting/settlement (code M) with an indicated price of $5.63 per share. After the settlement the reporting person beneficially owned 92,545 shares. The Form 4 was signed on 10/09/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.49%
Tags
insider
-
Rhea-AI Summary

William T. Boehm, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of Common Stock on 10/07/2025 at a reported per‑share value of $5.63. After the transaction Mr. Boehm beneficially owns 38,285 shares directly. The Form 4 was signed by an attorney‑in‑fact on 10/09/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.49%
Tags
insider
Rhea-AI Summary

Neogen Corp (NEOG) reported transactional and control updates for the quarter ended August 31, 2025. The company recognized a $76,390 gain on the sale of a business, received $121,724 in cash at closing (net of cash divested) and may receive up to $3,500 in contingent earnout consideration tied to 12 months of post‑closing revenue performance. The company made debt actions including $51,500 of principal activity on a Revolving Facility, $45,000 of prepayments on the Term Loan (generating a $393 extinguishment loss) and repurchased $3,500 million of Senior Notes (generating a $41 extinguishment loss). Management is strengthening internal controls, hiring dedicated control personnel, implementing document retention, and providing COSO framework training. The filing notes potential impacts from the Pillar Two global minimum tax rules and a forecasted top‑up tax mechanism, but no material top‑up tax was forecasted for foreign subsidiaries for the quarter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.49%
Tags
quarterly report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.49%
Tags
current report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
current report
Rhea-AI Summary

The filing describes how certain executive Performance Stock Units (PSUs) will be settled after the end of the Performance Period. An independent committee will compare the Companys actual performance to the pre-established metrics and apply an rTSR multiplier to determine how many PSUs, if any, are earned. Any earned PSUs will be converted into shares of the Companys common stock and issued to the named executive officer as soon as practicable, and those shares will be fully vested upon issuance. Until settlement, the PSUs do not give the executives any ownership interest or shareholder rights.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Neogen (NEOG)?

The current stock price of Neogen (NEOG) is $7.22 as of December 29, 2025.

What is the market cap of Neogen (NEOG)?

The market cap of Neogen (NEOG) is approximately 1.5B.
Neogen Corp

Nasdaq:NEOG

NEOG Rankings

NEOG Stock Data

1.55B
215.36M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING